NCT00244712 - Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV | Biotech Hunter

Enrollment

688

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

HIV Infection

Interventions

DRUG

emtricitabine/tenofovir

The intervention is an active comparator regimen containing tenofovir/emtricitabine + abacavir/lamivudine placebo + lopinavir/ritonavir.

DRUG

abacavir/lamivudine

The experimental intervention is a regimen containing abacavir/lamivudine + tenofovir/emtricitabine placebo + lopinavir/ritonavir.

Trial Locations (74)

10011

GSK Investigational Site, New York

10065

GSK Investigational Site, New York

14604

GSK Investigational Site, Rochester

19140

GSK Investigational Site, Philadelphia

19611

GSK Investigational Site, West Reading

20007

GSK Investigational Site, Washington D.C.

20009

GSK Investigational Site, Washington D.C.

20037

GSK Investigational Site, Washington D.C.

21201

GSK Investigational Site, Baltimore

22003

GSK Investigational Site, Annandale

22908

GSK Investigational Site, Charlottesville

23666

GSK Investigational Site, Hampton

24501

GSK Investigational Site, Lynchburg

27834

GSK Investigational Site, Greenville

28209

GSK Investigational Site, Charlotte

29206

GSK Investigational Site, Columbia

30033

GSK Investigational Site, Decatur

30308

GSK Investigational Site, Atlanta

30339

GSK Investigational Site, Atlanta

30912

GSK Investigational Site, Augusta

33040

GSK Investigational Site, Key West

33136

GSK Investigational Site, Miami

33306

GSK Investigational Site, Fort Lauderdale

33308

GSK Investigational Site, Fort Lauderdale

33316

GSK Investigational Site, Fort Lauderdale

33317

GSK Investigational Site, Plantation

33602

GSK Investigational Site, Tampa

33614

GSK Investigational Site, Tampa

33901

GSK Investigational Site, Fort Myers

34239

GSK Investigational Site, Sarasota

34243

GSK Investigational Site, Sarasota

34952

GSK Investigational Site, Port Saint Lucie

40202

GSK Investigational Site, Louisville

40536

GSK Investigational Site, Lexington

43614

GSK Investigational Site, Toledo

53226

GSK Investigational Site, Milwaukee

60153

GSK Investigational Site, Maywood

60612

GSK Investigational Site, Chicago

60637

GSK Investigational Site, Chicago

60657

GSK Investigational Site, Chicago

63108

GSK Investigational Site, St Louis

75208

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

75604

GSK Investigational Site, Longview

75708

GSK Investigational Site, Tyler

76104

GSK Investigational Site, Fort Worth

77027

GSK Investigational Site, Houston

77030

GSK Investigational Site, Houston

78550

GSK Investigational Site, Harlingen

78751

GSK Investigational Site, Austin

80204

GSK Investigational Site, Denver

80205

GSK Investigational Site, Denver

80220

GSK Investigational Site, Denver

85006

GSK Investigational Site, Phoenix

85012

GSK Investigational Site, Phoenix

85745

GSK Investigational Site, Tucson

89102

GSK Investigational Site, Las Vegas

90069

GSK Investigational Site, Los Angeles

90210

GSK Investigational Site, Beverly Hills

90813

GSK Investigational Site, Long Beach

92663

GSK Investigational Site, Newport Beach

92708

GSK Investigational Site, Fountain Valley

92845

GSK Investigational Site, Garden Grove

94602

GSK Investigational Site, Oakland

94609

GSK Investigational Site, Oakland

97219

GSK Investigational Site, Portland

06033

GSK Investigational Site, Glastonbury

06851

GSK Investigational Site, Norwalk

30308/30309

GSK Investigational Site, Atlanta

08844

GSK Investigational Site, Hillsborough

07102

GSK Investigational Site, Newark

08244

GSK Investigational Site, Somers Point

00731

GSK Investigational Site, Ponce

00909-1711

GSK Investigational Site, San Juan